Search research articles
Contact Us
Filters
Showing results (1-10 of 272) with videos related to
Page
of 28
Sort By:
BJU International
|
June 28, 2007
Hormone-refractory prostate cancer: what have we learned?
Manfred P Wirth
Archivos Espanoles De Urologia
|
March 12, 2019
New markers in prostate cancer: Genomics
Susanne Fuessel, Manfred P Wirth
European Urology
|
November 26, 2011
Impact factor for ranking academic urologic institutions
Manfred P Wirth, Michael Froehner
The Journal of Urology
|
May 20, 2015
Should the Urologist Treat Castration Resistant Prostate Cancer? Yes
Manfred P Wirth, Michael Froehner
European Urology
|
July 4, 2012
Words of wisdom. Re: Association of androgen deprivation therapy with cardiovascular death in patients with prostate cancer: a meta-analysis of randomized trials
Michael Froehner, Manfred P Wirth
European Urology
|
December 4, 2012
Re: Vincenzo Ficarra, Giacomo Novara, Raymond C. Rosen, et al. systematic review and meta-analysis of studies reporting urinary continence recovery after robot-assisted radical prostatectomy. Eur Urol 2012;62:405-17
Michael Froehner, Manfred P Wirth
European Urology
|
January 29, 2010
Robot-assisted radical prostatectomy: the new gold standard?
Manfred P Wirth, Michael Froehner
European Urology
|
October 6, 2014
Re: Firas Abdollah, Giorgio Gandaglia, Nazareno Suardi, et al. More Extensive Pelvic Lymph Node Dissection Improves Survival in Patients with Node-positive Prostate Cancer. Eur Urol 2015;67:212-9: Extended Lymph Node Dissection and the Will Rogers Phenomenon
Michael Froehner, Manfred P Wirth
The New England Journal of Medicine
|
October 30, 2014
Enzalutamide in metastatic prostate cancer before chemotherapy
Michael Froehner, Manfred P Wirth
Medizinische Monatsschrift Fur Pharmazeuten
|
June 29, 2018
Prostate cancer: Basics on clinical appearance, diagnostics and treatment
Christer Groeben, Manfred P Wirth
Page
of 28
Search research articles
Search
Showing results (1-10 of 272) with videos related to
Sort By:
Page
of 28
BJU International
|
June 28, 2007
Hormone-refractory prostate cancer: what have we learned?
Manfred P Wirth
Archivos Espanoles De Urologia
|
March 12, 2019
New markers in prostate cancer: Genomics
Susanne Fuessel, Manfred P Wirth
European Urology
|
November 26, 2011
Impact factor for ranking academic urologic institutions
Manfred P Wirth, Michael Froehner
The Journal of Urology
|
May 20, 2015
Should the Urologist Treat Castration Resistant Prostate Cancer? Yes
Manfred P Wirth, Michael Froehner
European Urology
|
July 4, 2012
Words of wisdom. Re: Association of androgen deprivation therapy with cardiovascular death in patients with prostate cancer: a meta-analysis of randomized trials
Michael Froehner, Manfred P Wirth
European Urology
|
December 4, 2012
Re: Vincenzo Ficarra, Giacomo Novara, Raymond C. Rosen, et al. systematic review and meta-analysis of studies reporting urinary continence recovery after robot-assisted radical prostatectomy. Eur Urol 2012;62:405-17
Michael Froehner, Manfred P Wirth
European Urology
|
January 29, 2010
Robot-assisted radical prostatectomy: the new gold standard?
Manfred P Wirth, Michael Froehner
European Urology
|
October 6, 2014
Re: Firas Abdollah, Giorgio Gandaglia, Nazareno Suardi, et al. More Extensive Pelvic Lymph Node Dissection Improves Survival in Patients with Node-positive Prostate Cancer. Eur Urol 2015;67:212-9: Extended Lymph Node Dissection and the Will Rogers Phenomenon
Michael Froehner, Manfred P Wirth
The New England Journal of Medicine
|
October 30, 2014
Enzalutamide in metastatic prostate cancer before chemotherapy
Michael Froehner, Manfred P Wirth
Medizinische Monatsschrift Fur Pharmazeuten
|
June 29, 2018
Prostate cancer: Basics on clinical appearance, diagnostics and treatment
Christer Groeben, Manfred P Wirth
Page
of 28